SCHEMBL7330656

SCHEMBL7330656

C=C(Br)CN(CC(=O)O)C(C)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.41
TDP1 Q9NUW8 2/20 0.32
EYA2 O00167 1/20 0.32
APP P05067 1/20 0.32
ACE P12821 1/20 0.32
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
CHRM2 P08172 1/20 0.31
ADRA2A P08913 1/20 0.31
ALOX15 P16050 1/20 0.31
TSHR P16473 1/20 0.31
DRD1 P21728 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
ADRA1A P35348 1/20 0.31
DRD3 P35462 1/20 0.31
BLM P54132 1/20 0.31
PMP22 Q01453 1/20 0.31
SLC6A3 Q01959 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2687920 0.83 TDP1 (0.43) CYP2C19TDP1EYA2APPACE
Water SCHEMBL7765705 0.81 TDP1 (0.41) CYP2C19TDP1EYA2APPACE
SCHEMBL6788905 0.81 TDP1 (0.41) CYP2C19TDP1EYA2APPACE
Water SCHEMBL7765711 0.81 TDP1 (0.41) CYP2C19TDP1EYA2APPACE
SCHEMBL7332844 0.78 TDP1 (0.32) CYP2C19TDP1EYA2APPACE
SCHEMBL7975927 0.77 TDP1 (0.38) CYP2C19TDP1EYA2APPACE
SCHEMBL9207405 0.75 CYP2C19 (0.38) CYP2C19
SCHEMBL4927059 0.75 TDP1 (0.36) CYP2C19TDP1EYA2APPACE
SCHEMBL7339429 0.74 CA14 (0.35) CYP2C19
SCHEMBL3714284 0.72 LMNA (0.39) CYP2C19TDP1EYA2APPACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5523289-A RENIN INHIBITOR ABBOTT LABORATORIES (US) 1996-06-04 US disclosed
EP-0456185-B1 Renin inhibitors ABBOTT LAB (US) 1995-05-31 EP disclosed
US-5344990-A Process for the preparation of a renin inhibiting compound ABBOTT LABORATORIES (US) 1994-09-06 US disclosed
US-5332742-A Ocular hypotensive ABBOTT LABORATORIES (US) 1994-07-26 US disclosed
US-5310740-A Congestive heart failure, hypotensive agents, antiglaucoma agents; side effect reduction ABBOTT LABORATORIES (US) 1994-05-10 US disclosed
US-5284849-A Treating hypertension and congestive heart failure ABBOTT LABORATORIES (US) 1994-02-08 US disclosed
US-5275950-A Process for the preparation of a renin inhibiting compound ABBOTT LABORATORIES (US) 1994-01-04 US disclosed
WO-1993007886-A1 PHARMACEUTICAL COMPOSITION CONTAINING CERTAIN PEPTIDOMIMETIC COMPOUNDS ABBOTT LABORATORIES (US) 1993-04-29 WO disclosed
WO-1993002667-A1 PHARMACEUTICAL COMPOSITION ABBOTT LABORATORIES (US) 1993-02-18 WO disclosed
US-5178877-A Cardiovascular disorders ABBOTT LABORATORIES (US) 1993-01-12 US disclosed
US-5122514-A Administering renin inhibitor ABBOTT LABORATORIES (US) 1992-06-16 US disclosed
EP-0456185-A2 Renin inhibitors ABBOTT LABORATORIES (US) 1991-11-13 EP disclosed